ResearcherGlasgow Royal InfirmaryActive in the last 2 years
Asif Ali
Matched on ORCID iD 0000-0002-3480-0060; OpenAlex author ID A5012212131. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 5
- Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients. First author DOI 10.1021/acsptsci.4c00490↗
- Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients. Co-author PMID 36628279↗
- Pharmacogenetics of treatments for pancreatic cancer. Co-author DOI 10.1080/17425255.2019.1620731↗
- Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2017.04.006↗
- MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarc… Co-author DOI 10.1158/1078-0432.ccr-11-0679↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elisa Giovannetti · 3 shared papers, 2017–2022 · strength 0.30
- Paper Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter… PMID 36628279↗
- Paper Pharmacogenetics of treatments for pancreatic cancer. DOI 10.1080/17425255.2019.1620731↗
- Paper Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. DOI 10.1016/j.semcancer.2017.04.006↗
- Adam Enver Frampton · 3 shared papers, 2017–2022 · strength 0.30
- Paper Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter… PMID 36628279↗
- Paper Pharmacogenetics of treatments for pancreatic cancer. DOI 10.1080/17425255.2019.1620731↗
- Paper Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. DOI 10.1016/j.semcancer.2017.04.006↗
- Abdul Salam · 1 shared paper, 2024 · strength 0.20
- Saifullah Afridi · 1 shared paper, 2024 · strength 0.20
- Thomas R. Jeffry Evans · 2 shared papers, 2012–2022 · strength 0.16
- Paper Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter… PMID 36628279↗
- Paper MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients wit… DOI 10.1158/1078-0432.ccr-11-0679↗
- Karin A. Oien · 2 shared papers, 2012–2022 · strength 0.16
- Paper Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter… PMID 36628279↗
- Paper MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients wit… DOI 10.1158/1078-0432.ccr-11-0679↗
- Nigel Balfour Jamieson · 2 shared papers, 2012–2022 · strength 0.16
- Paper Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter… PMID 36628279↗
- Paper MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients wit… DOI 10.1158/1078-0432.ccr-11-0679↗
- Colin J. McKay · 2 shared papers, 2012–2022 · strength 0.16
- Paper Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter… PMID 36628279↗
- Paper MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients wit… DOI 10.1158/1078-0432.ccr-11-0679↗
- Jennifer P. Morton · 2 shared papers, 2012–2022 · strength 0.16
- Paper Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter… PMID 36628279↗
- Paper MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients wit… DOI 10.1158/1078-0432.ccr-11-0679↗
- Owen James Sansom · 2 shared papers, 2012–2022 · strength 0.16
- Paper Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter… PMID 36628279↗
- Paper MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients wit… DOI 10.1158/1078-0432.ccr-11-0679↗
- Jaswinder Singh Samra · 1 shared paper, 2022 · strength 0.13
- Niccola Funel · 1 shared paper, 2022 · strength 0.13
- Anthony James Gill · 1 shared paper, 2022 · strength 0.13
- David Kuang-Fu Chang · 1 shared paper, 2022 · strength 0.13
- Andrew Victor Biankin · 1 shared paper, 2022 · strength 0.13
- Btissame El Hassouni · 1 shared paper, 2019 · strength 0.09
- Giovanna Li Petri · 1 shared paper, 2019 · strength 0.09
- Daniel Liu · 1 shared paper, 2019 · strength 0.09
- Stella Cascioferro · 1 shared paper, 2019 · strength 0.09
- Barbara Parrino · 1 shared paper, 2019 · strength 0.09
- Patrizia Diana · 1 shared paper, 2019 · strength 0.09
- Godefridus J. Peters · 1 shared paper, 2017 · strength 0.08
- Omidreza Firuzi · 1 shared paper, 2017 · strength 0.08
- Douglas C. Morran · 1 shared paper, 2012 · strength 0.03
- C. Ross Carter · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.